HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc06-2236v1 30/6/1624    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bulhões, K. Articles by Araújo, L. Search for Related Content PubMed PubMed Citation Articles by Bulhões, K. Articles by Araújo, L. Social Bookmarking                What's this?

Metabolic Syndrome in Hypertensive Patients

Correlation between anthropometric data and laboratory findings

From the School of Medicine, Federal University of Bahia, Salvador, Bahia, Brazil

Address correspondence and reprint requests to Kelminda Maria Bulhões Mendonça, Avenida Princesa Leopoldina, Edifício Cidade de Manaus 66, Apto 501, Graça, 40150-080 Salvador, Bahia, Brazil. E-mail: kelminda@ig.com.br

Abbreviations: ATPIII, Adult Treatment Panel III • IDF, International Diabetes Federation • NCEP, National Cholesterol Education Program

The first 20% of the full text of this article appears below.

	INTRODUCTION

 
Cardiovascular disease is the principal cause of morbidity and mortality in Brazil with a mortality coefficient of 442 per 100,000 inhabitants (1). In 90% of the individuals with a diagnosis of arterial hypertension, no causal agent is identified; however, current knowledge tends to suggest the importance of increased BMI (particularly as a result of visceral fat) in the physiopathology of this disease. In 1988, Reaven and Hoffman (2) identified the following components of a specific syndrome that would define increased cardiovascular risk: insulin resistance, glucose intolerance, hyperinsulinemia, elevated triglycerides, reduced HDL cholesterol, and arterial hypertension.

The prevalence of metabolic syndrome increases substantially with aging, as does the incidence of diabetes (3). Metabolic syndrome is strongly predictive of future diabetes (4), and its presence in hypertensive patients who may be at risk for diabetes should be investigated. The objective of the present study was to evaluate the prevalence of metabolic syndrome in hypertensive, nondiabetic outpatients.

	RESEARCH DESIGN AND METHODS—

 
This cross-sectional study included 102 hypertensive outpatients consecutively seen between December 2003 and May 2005 at a teaching hospital in Brazil. All patients included were aged >18 years with systemic arterial hypertension diagnosed according to the criteria defined by the IV Brazilian Guidelines for Arterial Hypertension (5). Exclusion criteria consisted of secondary hypertension, clinical or laboratory evidence of congestive heart failure, coronary disease, history of cerebral vascular accident, valve defect, or diabetes.

The following variables were evaluated: age, sex, . . . [Full Text of this Article]

	RESULTS—

 

	CONCLUSIONS—

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. C. Rodrigues, C. K. Kramer, T. Steemburgo, V. Dall'Alba, and M. J. Azevedo Metabolic Syndrome in Hypertensive Patients: Correlation Between Anthropometric Data and Laboratory Findings: Response to Bulhoes and Araujo Diabetes Care, December 1, 2007; 30(12): e140 - e140. [Full Text] [PDF]